Nanoadjuvant-triggered STING activation evokes systemic immunotherapy for repetitive implant-related infections

Nanoadjuvant-triggered STING activation evokes systemic immunotherapy for repetitive implant-related infections

Repetitive implant-related infections (IRIs) are devastating complications in orthopedic surgery, threatening implant survival and even the life of the host. Biofilms conceal bacterial-associated antigens (BAAs) and result in a ''cold tumor''-like immune silent microenvironment,...

Full description

Bibliographic Details
Main Authors:	Dongdong Xu, Jun Hu, Jiawei Mei, Jun Zhou, Zhengxi Wang, Xudong Zhang, Quan Liu, Zheng Su, Wanbo Zhu, Hongjian Liu, Chen Zhu
Format:	Article
Language:	English
Published:	KeAi Communications Co., Ltd. 2024-05-01
Series:	Bioactive Materials
Subjects:	Implant-related infections Systemic immunotherapy cGAS-STING pathway Interferon Neutrophil activation
Online Access:	http://www.sciencedirect.com/science/article/pii/S2452199X24000306

Similar Items

Recent advances in nanoadjuvant-triggered STING activation for enhanced cancer immunotherapy
by: Zicong Xu, et al.
Published: (2024-10-01)

Emerging mechanisms and implications of cGAS-STING signaling in cancer immunotherapy strategies
by: Jiawen Zhang, et al.
Published: (2024-01-01)

Comprehensive elaboration of the cGAS-STING signaling axis in cancer development and immunotherapy
by: Juyan Zheng, et al.
Published: (2020-08-01)

Salmonella Induces the cGAS-STING-Dependent Type I Interferon Response in Murine Macrophages by Triggering mtDNA Release
by: Lei Xu, et al.
Published: (2022-06-01)

The Chicken cGAS–STING Pathway Exerts Interferon-Independent Antiviral Function via Cell Apoptosis
by: Sen Jiang, et al.
Published: (2023-08-01)

Porcine cGAS-STING signaling induced autophagy inhibits STING downstream IFN and apoptosis
by: Nengwen Xia, et al.
Published: (2022-10-01)

The Innate Immune cGAS-STING-Pathway in Cardiovascular Diseases – A Mini Review
by: Lavinia Rech, et al.
Published: (2021-07-01)

Activation of Stimulation of Interferon Genes (STING) Signal and Cancer Immunotherapy
by: Kewang Luo, et al.
Published: (2022-07-01)

cGAS-STING pathway in pathogenesis and treatment of osteoarthritis and rheumatoid arthritis
by: XiCheng Yang, et al.
Published: (2024-05-01)

Increased cGAS/STING signaling components in patients with Mooren’s ulcer
by: Ya-Ni Zhang, et al.
Published: (2021-11-01)

SV40 Large T Antigen Is Not Responsible for the Loss of STING in 293T Cells but Can Inhibit cGAS-STING Interferon Induction
by: Joshua B. Reus, et al.
Published: (2020-01-01)

cGAS‐STING signaling in cancer: Regulation and therapeutic targeting
by: Xinzou Fan, et al.
Published: (2023-09-01)

Mechanism and therapeutic potential of targeting cGAS-STING signaling in neurological disorders
by: Yige Huang, et al.
Published: (2023-11-01)

Cancer immunotherapy strategies that target the cGAS-STING pathway
by: Zhuoying Tian, et al.
Published: (2022-10-01)

At the Crossroads of the cGAS-cGAMP-STING Pathway and the DNA Damage Response: Implications for Cancer Progression and Treatment
by: Tatyana V. Korneenko, et al.
Published: (2023-12-01)

Focus on the cGAS-STING Signaling Pathway in Sepsis and Its Inflammatory Regulatory Effects
by: Han Y, et al.
Published: (2024-06-01)

Activating cGAS-STING pathway for the optimal effect of cancer immunotherapy
by: Anping Li, et al.
Published: (2019-04-01)

The Role of STING-Mediated Activation of Dendritic Cells in Cancer Immunotherapy
by: Ribeiro AR, et al.
Published: (2024-10-01)

Clinical applications of STING agonists in cancer immunotherapy: current progress and future prospects
by: Bin Wang, et al.
Published: (2024-10-01)

Bidirectional regulation of the cGAS-STING pathway in the immunosuppressive tumor microenvironment and its association with immunotherapy
by: Yurui Zhang, et al.
Published: (2024-10-01)

STING Agonists/Antagonists: Their Potential as Therapeutics and Future Developments
by: Danilo Guerini
Published: (2022-03-01)

Regulation and Function of the cGAS-STING Pathway: Mechanisms, Post-Translational Modifications, and Therapeutic Potential in Immunotherapy
by: Chen Y, et al.
Published: (2025-03-01)

Regulating STING in health and disease
by: Yang Li, et al.
Published: (2017-06-01)

The cGas–Sting Signaling Pathway Is Required for the Innate Immune Response Against Ectromelia Virus
by: Wen-Yu Cheng, et al.
Published: (2018-06-01)

Updated roles of cGAS-STING signaling in autoimmune diseases
by: Ya Liu, et al.
Published: (2023-09-01)

Activation of the cGAS–STING signaling pathway in adenomyosis patients
by: Yun Lin, et al.
Published: (2021-09-01)

IUPHAR ECR review: The cGAS-STING pathway: Novel functions beyond innate immune and emerging therapeutic opportunities
by: Xu He, et al.
Published: (2024-03-01)

Ginkgetin Alleviates Inflammation and Senescence by Targeting STING
by: Yadan Liu, et al.
Published: (2025-01-01)

Nanomaterial-encapsulated STING agonists for immune modulation in cancer therapy
by: Xi Chen, et al.
Published: (2024-01-01)

STING Is Required in Conventional Dendritic Cells for DNA Vaccine Induction of Type I T Helper Cell- Dependent Antibody Responses
by: Justin Theophilus Ulrich-Lewis, et al.
Published: (2022-04-01)

cGAS-STING Signaling Pathway and Liver Disease: From Basic Research to Clinical Practice
by: Bangjie Chen, et al.
Published: (2021-08-01)

Development of Small-Molecule STING Activators for Cancer Immunotherapy
by: Hee Ra Jung, et al.
Published: (2021-12-01)

cGAS-STING pathway in cancer biotherapy
by: Yang Wang, et al.
Published: (2020-09-01)

The cGAS-STING pathway in ischemia-reperfusion injury in acute cerebral infarction: a new therapeutic opportunities?
by: Jun Hu, et al.
Published: (2024-12-01)

cGAS-STING signaling in cardiovascular diseases
by: Qianxin Zhang, et al.
Published: (2024-05-01)

The role of cGAS-STING pathway ubiquitination in innate immunity and multiple diseases
by: Chunyan Deng, et al.
Published: (2025-02-01)

Commentary: Type I Interferon Response Is Mediated by NLRX1-cGAS-STING Signaling in Brain Injury
by: Cali M. McEntee, et al.
Published: (2022-06-01)

Crosstalk between cGAS-STING pathway and autophagy in cancer immunity
by: Qijun Lu, et al.
Published: (2023-03-01)

Smart responsive Fe/Mn nanovaccine triggers liver cancer immunotherapy via pyroptosis and pyroptosis-boosted cGAS-STING activation
by: Qianying Du, et al.
Published: (2024-03-01)

cGAS-STING targeting offers therapy choice in lung diseases
by: Yu Wang, et al.
Published: (2025-02-01)